LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods

ASAIO Journal

Volumn 45, Issue 5, 1999, Pages 408-412

  Bambauer, Rolf ^a   Schiel, Ralf ^a   Latza, Reinhard ^a   Schneidewind, Jana Maria ^a  

^a Institute for Blood Purification   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; BEZAFIBRATE; CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; FENOFIBRATE; FIBRINOGEN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN;

ADULT; ALLERGIC REACTION; APHERESIS; ARTICLE; BLEEDING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DEVICE; DIET; DRUG USE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEMOPERFUSION; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; HYPOTENSION; IMMUNOADSORPTION; LIPOPROTEIN BLOOD LEVEL; MALE; SAFETY; SHOCK; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

EID: 0033200931     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199909000-00008     Document Type: Article

References (11)

1. Assmann C, Schulter H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (The PROCAM experience). Am) Cardiovasc 70: 733-737, 1992.
2. Brown BG, Albers JJ, Fisher LD, et al: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B (FATS). N Engl J Med 323: 1289-1298, 1990.
3. Hjermann I, Holme I, Leven P: Oslo diet study and antismoking trial. Results after 102 months. Am J Med 80: 701-711, 1986.
4. Huttunen JK, Manninen V, Mänttäri M, et al: The Helsinki heart study: central findings and clinical implications. Ann Med 23: 155-159, 1991.
5. Kannel WB, Casteli WP, Gordon T, McNamanra PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham Study. Ann Intern Med 74:1-12, 1971.
6. Wannamethee G, Shaper AG, Shincup PH, Walter M: Low serum cholesterol concentrations and mortality in middle aged British men. Br Med J 311:409-413, 1995.
7. McGill HC: Persistent problems in the pathogenesis of atherosclerosis. Atherosclerosis 4: 443-451, 1984.
8. Brett AS: Treating hypercholesterolemia: How should practicing physicians interpret the published date for patients? N Engl J Med 321: 676-680, 1989.
9. Laaf A: Management of hypercholesterolemia: are preventive interventions advisable? N Engl J Med 321: 680-684, 1989.
10. Yudkin JS: How can we best prolong life? Benefits of coronary risk factor reduction in non- diabetic and diabetic subjects. Br Med J 306: 1313-1318, 1993.
11. Epstein FH: Beyond cholesterol. N Engl J Med 320: 915-924, 1989.